Clofedanol

(Redirected from Chlophedianol)
Jump to: navigation, search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Clofedanol

Articles

Most recent articles on Clofedanol

Most cited articles on Clofedanol

Review articles on Clofedanol

Articles on Clofedanol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Clofedanol

Images of Clofedanol

Photos of Clofedanol

Podcasts & MP3s on Clofedanol

Videos on Clofedanol

Evidence Based Medicine

Cochrane Collaboration on Clofedanol

Bandolier on Clofedanol

TRIP on Clofedanol

Clinical Trials

Ongoing Trials on Clofedanol at Clinical Trials.gov

Trial results on Clofedanol

Clinical Trials on Clofedanol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Clofedanol

NICE Guidance on Clofedanol

NHS PRODIGY Guidance

FDA on Clofedanol

CDC on Clofedanol

Books

Books on Clofedanol

News

Clofedanol in the news

Be alerted to news on Clofedanol

News trends on Clofedanol

Commentary

Blogs on Clofedanol

Definitions

Definitions of Clofedanol

Patient Resources / Community

Patient resources on Clofedanol

Discussion groups on Clofedanol

Patient Handouts on Clofedanol

Directions to Hospitals Treating Clofedanol

Risk calculators and risk factors for Clofedanol

Healthcare Provider Resources

Symptoms of Clofedanol

Causes & Risk Factors for Clofedanol

Diagnostic studies for Clofedanol

Treatment of Clofedanol

Continuing Medical Education (CME)

CME Programs on Clofedanol

International

Clofedanol en Espanol

Clofedanol en Francais

Business

Clofedanol in the Marketplace

Patents on Clofedanol

Experimental / Informatics

List of terms related to Clofedanol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Clofedanol (INN) or chlophedianol (BAN) is a centrally acting cough suppressant used in the treatment of dry cough. Clofedanol has local anesthetic and antihistamine properties, and may have anticholinergic effects at high doses.[1] It is marketed in Canada under the trade name Ulone, but is not available currently in the United States. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name Clofera. It has a release to market date in the beginning of the fourth quarter 2009.[2] Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process[3] and its safety and efficacy data are limited.

Synthesis

Clofedanol synthesis: R. Lorenz and H. Henecka, Template:US Patent (1962).

References

  1. "Clofedanol" (in français). BIAM. 1998-07-24. Retrieved 2007-04-15.
  2. "Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion". Cenrx.com. Retrieved 2009-09-27.
  3. "Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57" (PDF). FDA.gov. 1987-08-12.

Linked-in.jpg